Clinical Characteristics, Tumor, Node, Metastasis Status, and Mutation Rate in Domain of Epidermal Growth Factor Receptor Gene in Serbian Patients with Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Clinical Characteristics, Tumor, Node, Metastasis Status, and Mutation Rate in Domain of Epidermal Growth Factor Receptor Gene in Serbian Patients with Lung Adenocarcinoma

Published:2014-09 Issue:9 Volume:9 Page:1406-1410
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Zaric Bojan,Stojsic Vladimir,Kovacevic Tomi,Sarcev Tatjana,Tepavac Aleksandar,Jankovic Radmila,Spasic Jelena,Radosavljevic Davorin,Zarogoulidis Paul,Vukobradovic-Djoric Nevena,Perin Branislav

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. High efficacy of first-line gefitinib in non-Asian patients with EGFR-mutated lung adenocarcinoma;Moiseyenko;Onkologie,2010

2. Detection of EGFR gene mutations in non-small cell lung cancer: lessons from a single-institution routine analysis of 1,403 tumor samples;Vallee;Int J Oncol,2013

3. EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy;Milella;J Thorac Oncol,2012

4. Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer;Tsao;J Thorac Oncol,2006

5. EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgery;Helland;J Thorac Oncol,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adequacy of biopsy samples for epidermal growth factor receptor (EGFR) molecular testing in lung adenocarcinoma;Vojnosanitetski pregled;2021

2. Non-small cell lung cancer patients with ex19del or exon 21 L858R mutation: distinct mechanisms, different efficacies to treatments;Journal of Cancer Research and Clinical Oncology;2020-06-28

3. PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy;Lung Cancer;2020-04

4. Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland;Diagnostic Pathology;2019-02-11

5. Correlation between high-resolution computed tomography lung nodule characteristics and EGFR mutation in lung adenocarcinomas;OncoTargets and Therapy;2019-01